{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T15:21:15Z","timestamp":1781191275102,"version":"3.54.1"},"reference-count":32,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T00:00:00Z","timestamp":1727395200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Chinese Journal of Diabetes","award":["2119000446"],"award-info":[{"award-number":["2119000446"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceuticals"],"abstract":"<jats:p>Background\/Objectives: Metabolic-associated fatty liver disease (MAFLD) is one of the most common liver disorders associated with obesity and metabolic syndrome, and poses a significant global health burden with limited effective treatments. The aim of this study was to assess the protective effects of mulberry twig alkaloids (SZ-A) on MAFLD and to further investigate the underlying mechanisms including the specific targets or pathways. Methods: Diet-induced obesity (DIO) and normal mouse models were established by feeding C57Bl\/6J mice with a high-fat diet (HFD) or common diet for 12 weeks. SZ-A, dapagliflozin, and placebo were administered to corresponding mouse groups for 8 weeks. Data of fasting blood glucose, glucose tolerance, insulin tolerance, and the body weight of mice were collected at the baseline and termination of the experiment. Serum liver enzymes and lipids were measured by ELISA. Western blotting, qPCR, and pathological section staining were implemented to evaluate the degrees of liver steatosis, fibrosis, and oxidative stress in mice. Results: In DIO mouse models, high-dose SZ-A (800 mg\/kg\/d) treatment significantly inhibited HFD-induced weight gain, improved insulin tolerance, and reduced serum alanine aminotransferase, total cholesterol, and triglyceride levels compared with placebo. In DIO mice, SZ-A could alleviate the pathological changes of hepatic steatosis and fibrosis compared with placebo. Lipid catabolism and antioxidant stress-related proteins were significantly increased in the livers of the high-dose SZ-A group (p &lt; 0.05). Inhibition of PGC1\u03b1 could inhibit the function of SZ-A to enhance lipid metabolism in hepatocytes. PGC1\u03b1 might interact with NRF2 to exert MAFLD-remedying effects. Conclusions: By regulating the expression of PGC1\u03b1 and its interacting KEAP1\/NRF2 pathway in mouse liver cells, SZ-A played important roles in regulating lipid metabolism, inhibiting oxidative stress, and postponing liver fibrosis in mice with MAFLD.<\/jats:p>","DOI":"10.3390\/ph17101287","type":"journal-article","created":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T11:19:33Z","timestamp":1727435973000},"page":"1287","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Mulberry Twig Alkaloids Improved the Progression of Metabolic-Associated Fatty Liver Disease in High-Fat Diet-Induced Obese Mice by Regulating the PGC1\u03b1\/PPAR\u03b1 and KEAP1\/NRF2 Pathways"],"prefix":"10.3390","volume":"17","author":[{"given":"Mengqing","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Endocrinology and Metabolism, Peking University People\u2019s Hospital, Beijing 100044, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengcheng","family":"Guo","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Peking University People\u2019s Hospital, Beijing 100044, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zonglin","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Peking University People\u2019s Hospital, Beijing 100044, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7881-0543","authenticated-orcid":false,"given":"Xiaoling","family":"Cai","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Peking University People\u2019s Hospital, Beijing 100044, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Wen","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Peking University People\u2019s Hospital, Beijing 100044, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Lv","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Peking University People\u2019s Hospital, Beijing 100044, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chu","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Peking University People\u2019s Hospital, Beijing 100044, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linong","family":"Ji","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Peking University People\u2019s Hospital, Beijing 100044, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,9,27]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1002\/hep.24376","article-title":"Endpoints and clinical trial design for nonalcoholic steatohepatitis","volume":"54","author":"Sanyal","year":"2011","journal-title":"Hepatology"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.1210\/clinem\/dgac321","article-title":"Global Prevalence and Clinical Characteristics of Metabolic Associated Fatty Liver Disease. A Meta-Analysis and Systematic Review of 10,739,607 Individuals","volume":"107","author":"Chan","year":"2022","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"846","DOI":"10.4254\/wjh.v7.i6.846","article-title":"Non-alcoholic fatty liver disease: The diagnosis and management","volume":"7","year":"2015","journal-title":"World J. Hepatol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S2468-1253(22)00165-0","article-title":"The prevalence and incidence of NAFLD worldwide: A systematic review and meta-analysis","volume":"7","author":"Riazi","year":"2022","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1097\/MCG.0000000000001739","article-title":"Global Burden of Nonalcoholic Fatty Liver Disease, 1990 to 2019: Findings from the Global Burden of Disease Study 2019","volume":"57","author":"Jiang","year":"2023","journal-title":"J. Clin. Gastroenterol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.celrep.2018.12.036","article-title":"Genetic Liver-Specific AMPK Activation Protects against Diet-Induced Obesity and NAFLD","volume":"26","author":"Garcia","year":"2019","journal-title":"Cell Rep."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Wu, S.-J., Huang, W.-C., Yu, M.-C., Chen, Y.-L., Shen, S.-C., Yeh, K.-W., and Liou, C.-J. (2021). Tomatidine ameliorates obesity-induced nonalcoholic fatty liver disease in mice. J. Nutr. Biochem., 91.","DOI":"10.1016\/j.jnutbio.2021.108602"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Lee, G.-H., Peng, C., Park, S.-A., Hoang, T.-H., Lee, H.-Y., Kim, J., Kang, S.-I., Lee, C.-H., Lee, J.-S., and Chae, H.-J. (2020). Citrus Peel Extract Ameliorates High-Fat Diet-Induced NAFLD via Activation of AMPK Signaling. Nutrients, 12.","DOI":"10.3390\/nu12030673"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Li, L., Fu, J., Liu, D., Sun, J., Hou, Y., Chen, C., Shao, J., Wang, L., Wang, X., and Zhao, R. (2020). Hepatocyte-specific Nrf2 deficiency mitigates high-fat diet-induced hepatic steatosis: Involvement of reduced PPAR\u03b3 expression. Redox Biol., 30.","DOI":"10.1016\/j.redox.2019.101412"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Chen, Y.-M., Lian, C.-F., Sun, Q.-W., Wang, T.-T., Liu, Y.-Y., Ye, J., Gao, L.-L., Yang, Y.-F., Liu, S.-N., and Shen, Z.-F. (2022). Ramulus Mori (Sangzhi) Alkaloids Alleviate High-Fat Diet-Induced Obesity and Nonalcoholic Fatty Liver Disease in Mice. Antioxidants, 11.","DOI":"10.3390\/antiox11050905"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"7121356","DOI":"10.1155\/2016\/7121356","article-title":"Randomized, Double-Blinded, Double-Dummy, Active-Controlled, and Multiple-Dose Clinical Study Comparing the Efficacy and Safety of Mulberry Twig (Ramulus Mori, Sangzhi) Alkaloid Tablet and Acarbose in Individuals with Type 2 Diabetes Mellitus","volume":"2016","author":"Li","year":"2016","journal-title":"Evid. Based Complement. Altern. Med."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Lei, L., Huan, Y., Liu, Q., Li, C., Cao, H., Ji, W., Gao, X., Fu, Y., Li, P., and Zhang, R. (2022). Morus alba L. (Sangzhi) Alkaloids Promote Insulin Secretion, Restore Diabetic \u03b2-Cell Function by Preventing Dedifferentiation and Apoptosis. Front. Pharmacol., 13.","DOI":"10.3389\/fphar.2022.841981"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Liu, Q., Liu, S., Cao, H., Ji, W., Li, C., Huan, Y., Lei, L., Fu, Y., Gao, X., and Liu, Y. (2021). Ramulus Mori (Sangzhi) Alkaloids (SZ-A) Ameliorate Glucose Metabolism Accompanied by the Modulation of Gut Microbiota and Ileal Inflammatory Damage in Type 2 Diabetic KKAy Mice. Front. Pharmacol., 12.","DOI":"10.3389\/fphar.2021.642400"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.metabol.2018.11.014","article-title":"Obesity and nonalcoholic fatty liver disease: From pathophysiology to therapeutics","volume":"92","author":"Polyzos","year":"2019","journal-title":"Metabolism"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"3361","DOI":"10.3748\/wjg.v24.i30.3361","article-title":"Current guidelines for the management of non-alcoholic fatty liver disease: A systematic review with comparative analysis","volume":"24","author":"Leoni","year":"2018","journal-title":"World J. Gastroenterol."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Cheng, C.-F., Ku, H.-C., and Lin, H. (2018). PGC-1\u03b1 as a Pivotal Factor in Lipid and Metabolic Regulation. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19113447"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/nrm.2017.95","article-title":"AMPK: Guardian of metabolism and mitochondrial homeostasis","volume":"19","author":"Herzig","year":"2018","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Ramatchandirin, B., Pearah, A., and He, L. (2023). Regulation of Liver Glucose and Lipid Metabolism by Transcriptional Factors and Coactivators. Life, 13.","DOI":"10.3390\/life13020515"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1210\/er.2018-00064","article-title":"Molecular Actions of PPAR\u03b1 in Lipid Metabolism and Inflammation","volume":"39","author":"Bougarne","year":"2018","journal-title":"Endocr. Rev."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"101117","DOI":"10.1016\/j.plipres.2021.101117","article-title":"PARPs in lipid metabolism and related diseases","volume":"84","author":"Gupte","year":"2021","journal-title":"Prog. Lipid Res."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.jhep.2020.09.037","article-title":"Hepatocyte-specific NRF2 activation controls fibrogenesis and carcinogenesis in steatohepatitis","volume":"74","author":"Mohs","year":"2021","journal-title":"J. Hepatol."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Ge, C., Tan, J., Lou, D., Zhu, L., Zhong, Z., Dai, X., Sun, Y., Kuang, Q., Zhao, J., and Wang, L. (2022). Mulberrin confers protection against hepatic fibrosis by Trim31\/Nrf2 signaling. Redox Biol., 51.","DOI":"10.1016\/j.redox.2022.102274"},{"key":"ref_23","first-page":"1313","article-title":"High-intensity interval training reduced oxidative stress and apoptosis in the hippocampus of male rats with type 2 diabetes: The role of the PGC1\u03b1-Keap1-Nrf2 signaling pathway","volume":"26","author":"Ebrahimnezhad","year":"2023","journal-title":"Iran. J. Basic Med. Sci."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Liu, S., Pi, J., and Zhang, Q. (2022). Signal amplification in the KEAP1-NRF2-ARE antioxidant response pathway. Redox Biol., 54.","DOI":"10.1016\/j.redox.2022.102389"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"120111","DOI":"10.1016\/j.lfs.2021.120111","article-title":"Nrf2\/Keap1\/ARE signaling: Towards specific regulation","volume":"291","author":"Ulasov","year":"2022","journal-title":"Life Sci."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1152\/physrev.00023.2017","article-title":"The KEAP1-NRF2 System: A Thiol-Based Sensor-Effector Apparatus for Maintaining Redox Homeostasis","volume":"98","author":"Yamamoto","year":"2018","journal-title":"Physiol. Rev."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.tem.2017.10.003","article-title":"Insights into Stearoyl-CoA Desaturase-1 Regulation of Systemic Metabolism","volume":"28","author":"Aljohani","year":"2017","journal-title":"Trends Endocrinol. Metab."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.cmet.2007.10.014","article-title":"Hepatic stearoyl-CoA desaturase-1 deficiency protects mice from carbohydrate-induced adiposity and hepatic steatosis","volume":"6","author":"Miyazaki","year":"2007","journal-title":"Cell Metab."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"3534","DOI":"10.7150\/thno.70194","article-title":"SCD1\/FADS2 fatty acid desaturases equipoise lipid metabolic activity and redox-driven ferroptosis in ascites-derived ovarian cancer cells","volume":"12","author":"Xuan","year":"2022","journal-title":"Theranostics"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1007\/s40618-021-01501-y","article-title":"Prevalence of hepatic steatosis in patients with type 2 diabetes and response to glucose-lowering treatments. A multicenter retrospective study in Italian specialist care","volume":"44","author":"Morieri","year":"2021","journal-title":"J. Endocrinol. Investig."},{"key":"ref_31","unstructured":"National Research Council (2011). Guide for the Care and Use of Laboratory Animals, The National Academies Press. [8th ed.]."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1186\/1475-2875-6-169","article-title":"Improved isolation of murine hepatocytes for in vitro malaria liver stage studies","volume":"6","year":"2007","journal-title":"Malar. J."}],"container-title":["Pharmaceuticals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1424-8247\/17\/10\/1287\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T16:05:29Z","timestamp":1760112329000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1424-8247\/17\/10\/1287"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,27]]},"references-count":32,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2024,10]]}},"alternative-id":["ph17101287"],"URL":"https:\/\/doi.org\/10.3390\/ph17101287","relation":{},"ISSN":["1424-8247"],"issn-type":[{"value":"1424-8247","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,27]]}}}